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Abstract: 
The performance of the porous glass ceramic doped with 10 % wt Zinc and 2% wt TiN 
(46S6-10Zn) ,in the restoration of critical diaphyseal bone defect, was evaluated by 
several physicochemical methods and histological studies. The critical defect in rabbits 
was created and then filled with 46S6-10Zn. At different periods after implementation, 
animals were sacrificed. Samples were harvested for exploration. The nuclear magnetic 
resonance (MAS-NMR) of 31P and 29Si illustrates the progressive degradation of 46S6-
10Zn in favor to of the formation and the development of biological apatite. Therefore, 
after one month of implementation, MAS- NMR 29Si proves the presence of Q2 (25%), 
Q3 (73%) and Q4 (2%). However, after six months, the disappearance of all these 
species was revealed and characterized by the 46S6-10Zn dissolution. Besides, MAS- 
NMR 31P demonstrates the presence of Qc0 (4%), QHA0 (55%) and Qa0 (41%) after one 
month. Nevertheless, six months later, we observe the presence of QHA0 (80%) and Qa0 
(20%). Histological study  demonstrates an intimate contact of 46S6-10Zn surrounding 
bone after one month of implantation. However, after four months, mature bone matrix 
became calcified and the implanted 46S6-10Zn began to be degraded. Moreover, nine 
months later, 46S6-10Zn was nearly resorbed and replaced by a calcified tissue in 
the periphery and an osteoid tissue in the middle of bone defects.  
 
Key words: Porous glass ceramic ; Nuclear magnetic resonance; Crystalline structure; 
Cells attachment. 
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1. Introduction: 
Bone defects caused by various reasons such as trauma, infection, tumor, congenital 
deformity, etc., still a clinically unsolved puzzle. The autogenous bone transplantation is 
the optimum choice today, but  it cannot satisfy the clinical demand because of its 
limited source and even worse, it may causes  damage to the donor site of 
transplantation or even complications, sometimes [1]. This problem leads experts to 
discover synthetic materials that have a potential restorative effect of bone defects. In 
this study we are interested in bioactive glasses (46S6) as support doped with Zinc (Zn) 
and titanium (Ti).    
 Bioactive glasses are widely used in the clinical repair of bone defects, because they are 
spontaneously bonded and  integrated with the bone in the living body through the rapid 
formation of a thin hydroxycarbonate-apatite layer on the material surface when 
implanted or in contact with biological fluids [2].  Bioactive glasses are a subset of 
inorganic bioactive materials as well, which are capable of reacting with physiological 
fluids to form tenacious bonds to the bone through the formation of bone-like 
hydroxyapatite layers and the biological interaction of collagen with the material 
surface [3]. It has been found that reactions on bioactive glass surfaces lead to the 
release of critical concentrations of soluble Silicon (Si), Calcium (Ca), Phosphorus (P) 
and Sodium (Na) ions, which induce favorable intracellular and extracellular responses, 
leading to the rapid bone formation [4]. Bioactive glass is an amorphous system which 
promotes its association with other elements such as strontium [5], magnesium [6] and 
zinc [7] and other molecules such as bisphonates [8]. Zinc is an essential trace element 
for the boby. It assures several functions: metabolism of cells [9], wound healing [10] 
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and it stimulates cell proliferation and differentiation, protein synthesis in osteoblastic 
cells [10,11] as well. In a previous study, it was demonstrated that, after immersion of 
46S6 and 46S6-10Zn in the SBF, the incorporation of Zn in the vitreous matrix based 
on 46S6 increases the bioactivity of this biomaterial [7]. This highlights the role of zinc 
in the development, differentiation and  proliferation of osteoblasts. Its deficiency 
decreases bone weight and delays growth in bone metabolism. Zinc deficiency results in 
a retardation of  bone growth, development, and maintenance of bone health [12, 13]. It 
has a stimulatory effect on bone formation and mineralization in vitro and vivo [14, 15]. 
The biocompatibility of  46S6-10Zn was maximized by the incorporation of titanium in 
its matrix. Therefore, it was reported that the excellent biocompatibility of titanium and 
its alloys with bone tissue can be explained by the unique characteristics of titanium-
bone interface [16]. 
Our study aimed to evaluate the behavior of porous glass ceramic doped with Zn and Ti 
in the restoration of critical diaphyseal bone defect in rabbits after its implementation 
during one, four, six and nine months. 
 For the evaluation of our biomaterial’s behavior (46S6-10Zn), several physicochemical 
techniques were used such as X- ray diffraction (DRX), Infra- red analysis (FTIR), 
Energy-dispersive X-ray (EDS) and solid-state nuclear magnetic resonance (MAS- 
NMR). The evolution of initial biomaterial was realized in function of the time 
implementation. Additionally, the histological study was used to evaluate the 
osseointegration and the resorption of this composite after one, four and nine months. 
 
2. Materials and Methods:  
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       2.1 Bioactive glass synthesis 
Bioactive glasses were synthesized by freeze-drying method. Their elaboration was 
carried out using sodium metasilicate (Na2SiO3), silicon dioxide (SiO2), calcium 
metasilicate (CaSiO3) and sodium metaphosphate (Na3P3O9). Powders were weighed 
and mixed in a polyethylene bottle, for 2h using a planetary mixer. 46S6-10Zn was 
synthesized from the composition of 46S6 (46 mass%SiO2 (silica), 24 mass% CaO 
(calcium oxide or lime), 24 mass% Na2O (Sodium oxide) and 6 mass%P2O5 
(Phosphorus pentoxide). Moreover, this bioactive glass composition 46S6 was studied 
by introducing 10 mass% zinc oxide and 2 mass% TiN to create porosity [17].  
The premixed mixtures were melted at 1250°C in platinum crucibles to avoid the risk of 
contamination. The fusion temperature of platinum is of 1760°C. The first rise of 
temperature rate was 10°C min-1 and was held at 900°C for 1h to achieve the 
decarbonatation of all products. The samples were cast in preheated brass molds, in 
order to form cylinders of 13 mm in diameter, and annealed at 565°C for 4h near the 
glass transition temperature. The obtained cylinders were used for the ‘in vivo’ studies. 
The prepared bioimplants were sterilized by γ-irradiation from a 60Co source gamma 
irradiation at a dose of 25 Gy (Equinox, UK) using standard procedures for medical 
devices. 
 
2.2 Animal model 
 
Twenty five mature New Zealand rabbits, nine months old and weighing 1.6-2 kg, were 
used. Animals were bred in the Central Animal House and they were randomly 
distributed into 2 groups:  
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*G1 (T) none operated and none implanted,   
*G2 (46S6-10Zn) operated and implanted with 46S6-10Zn.  
The animals were placed in individual cages, under standard conditions (room 
temperature 22 ± 2°C, relative humidity 55 ± 5% and illumination with a 12 h/12 h of 
light/darkness photoperiod), fed with a full rabbit’s on a pellet diet (Sico, Sfax, Tunisia), 
libitum added water, and without restriction of movement, according to the animal 
experimentation EU rules. 
 
2.3 Animal anesthesia 
 
Anesthesia was induced with 10 mg / kg of ketamine (KetaminoL, Intervet International 
GmbH, Unterschleibheim, Germany) and 0.1 mg / kg of Xylazine (Rompun, Bayer 
Healthcare, PuteauxFrance). Supplemented local anesthesia was applied after 15 - 20 
min using 4 mg / kg carprofen (Rimadyl, Pfizer, Paris, France) depending on body 
weight.  
 
2.4 Surgical operations 
 
The tibia was implanted and stabilized by mini external fixator. Cutaneous and 
subcutaneous incisions on the inner face of the tibia followed by an opening of the 
muscular aponeurose were carried out. A gap (1 cm in diameter) in the mid-diaphyseal 
level of the tibia was created aseptically. 46S6-10Zn filled the loss of osseous substance 
for the second group. Animals were killed after one, four, six and nine months and 
bones were harvested (Fig. 1). 
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2.5 Physicochemical exploration 
 
The evaluation of the crystalline and morphological structure of the surface and the 
kinetic of bioimplant degradation and resorption were carried out by using 
complementary methods such as XRD, FTIR, EDS and MAS- NMR. X-ray diffraction 
(XRD) was studied by using a diffractometer (Philips X'Pert-MPD system with a CuKa 
wave length of 1.5418Å). The diffractometer was operated at 40 kV and 30 mA at a 2θ 
range from 10°–70° employing a step size of 0.02°/s. Samples were dried for 24 h at 65 
°C and weighed accurately. Fourier transformed infrared analysis (FTIR; Nicolet 
Magna-IR 550 spectrometers, Madison, Wisconsin) was performed to identify the 
nature of the chemical groups and their evolution versus time of implementation. The 
samples were small pellets, of 0.5 cm diameter, obtained by pressing the   powder with 
KBr. Quantification of calcium (Ca, mol %), phosphorus (P, mol %) and zinc (Zn, mol 
%) in the interface 46S6-10Zn- bone was determined by the dispersive X-ray 
spectroscopic additionally the ratio of calcium to phosphorus (Ca/P) was calculated at 
each period. Nuclear Magnetic Resonance (NMR) using a Bruker MAS spectrometer 
ASX300 (7.05 T) was employed to highlight the new formation of bone and the 
degradation of biomaterial. 
 
2.6 Histological studies 
 
The cells’ attachment and bone formation have been studied by using histological study. 
After one, four and nine months the implanted bone was harvested from each rabbit and 
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fixed in Burdack, (formalin). The time delay was selected to assess the performance of 
the biomaterials on bone formation before degradation. Samples were included in a 
mixture of polymethylmethacrylate (PMMA) and glycolmthacrylate (GMA) without 
prior decalcification. Sections 6 to 7 μm thick were debited along a transverse plane 
using a sliding microtome (Reichert-Jung). 
 
    2.7 Statistical analysis 
 
The statistical analysis of the data was carried out using the Student’s t-test. The 
determinations were performed from 5 animals per group. All values were expressed 
as means ± SE at the significance level 2a=0.05 
 
3. Results  
 
      3.1 Crystalline structure by using X-ray diffraction (XRD) 
 
Data reported by XRD show structural changes of the porous glass ceramic before 
and after implementation. Therefore, before implementation, biomaterial shows the 
presence of two crystal phases referenced in JCPDS: major crystalline phase 
(Na4Ca4Si6O18) and a secondary crystalline  phase (Na2Ca4 (PO4)2SiO4) as shown in Fig. 
2. After one month of implementation , we observe the persistence of these two phases 
of the 46S6-10Zn (Na4Ca4Si6O18 and  Na2Ca4 (PO4)2SiO4). This result exhibits the onset 
degradation of this composite. Four months later, the diffractogram illustrates the 
disappearance of the two phases of 46S6-10Zn and the appearance of two lines of 
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biological apatite which indicate the progressive mineralization and nucleation of bone. 
Finally, after nine months we observe a diffractogram similar to that of biological bone. 
All these findings demonstrate the biodegradability of 46S6-10Zn and its progressive 
replacement by the apatite (Fig. 2).  
    
3.2 Molecular vibrations: Infra- red analysis (FTIR) 
Spectrum of 46S6-10Zn before and after its implementation (Fig. 3) illustrates  
several changings. 46S6-10Zn before implementation, indicates the presence of 4 bands 
of   Si-O-Si at a wave-number 503 cm-1 and Si-O at 745, 932 and 1036 cm-1. In 
addition, we note the presence of three bands of  P-O at the wave-numbers 580, 645 and 
1048 cm-1. One month later of implementation, we observe the presence of three bands 
of Si-O respectively at the wave-number of 448, 526 and 920 cm-1. Also, we notice the 
presence of  P-O bands and with a chemical displacement respectively at the 
wavelength of 620, 566 and 1028 cm-1. Whereas, the absorption bond at 1657 cm-1 is 
attributed to amide I. Moreover, the band at 154 cm-1 corresponds to the amide II. All 
these findings suggest the beginning  of 46S6-10Zn degradation and its replacement by 
the newly formed bone cells compared to carbonated hydroxyapatite used as a reference 
(Fig. 3).  After four months, we illustrate the increasing of biomaterial degradation. 
Therefore, we notice the presence of Si-O bands with a slight intensity.  Moreover, we 
show the increasing of bonds characterizing amide I and II, besides, we observe the 
appearance of amide III and the bands of carbonate at the wave numbers 1242, 872, 
1409 and 1455 cm-1. These findings explain the disappearance of 46S6-10Zn  matrix in 
favor of the overlapping of the apatite bands. These bands were replaced by 601 cm-
1,564 cm-1and 1028 cm-1 (P-O) group arising from that of the apatite- bone. The P-O 
10 
 
intensity increased with the advance of implementation time, this exhibits the 
progression of bone growth with implementation time. This is confirmed by the 
appearance of the C-O band characteristic of bone carbonate group.  Moreover, after 
nine months, all Si-O bands disappeared and replaced by P-O bands, amide I, II, III and 
carbonates. This highlights the increasing of ours biomaterial (46S6-10Zn) 
biodegradation and the bone mineralization and  formation.  
 
3.3 Evolution of the mineral composition: Energy- dispersive (EDS) 
 As shown in Fig. 4, before implementation, 46S6-10Zn shows a phosphocalcic Ca/P 
ratio of 2.67. After implementation, this value decreased. Therefore, after one month, 
the attenuation of  Ca/P value  to 1.33 can be explained by the exchanges of these two 
elements Ca and P between biomaterial and nearby tissue. This interchange may lead 
for the mineralization and the crystallization of the new formed bone.  
 This Ca/P  value exhibits the absence of calcium phosphate. Four months later, this 
value increased to 1.66 which explains the mineralization and the formation of the 
biological apatite in the interface bone / 46S6-10Zn. After nine months, the Ca/P ratio is 
near to 1.88 which highlights the progression of the bone mineralization. Whereas, 
silicon value shows a modification before and after implementation, in fact before 
implementation it was near to 47. After one month of implementation, we observe a 
height concentration of Si and Zn. This demonstrates the slowly dissolution of the 
46S6-10Zn matrix. After four months, we observe a decreasing of Si and Zn 
concentrations. This highlights the progressive degradation of the 46S6-10Zn. Nine 
months later, we note a total absence of Si and the reduction of Zn value. Data reported 
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after nine months explains the degradation and the resorption of 46S6-10Zn and its 
replacement by bone (Fig. 5).  
 
3.4 Structural evolution after in vivo tests: Nuclear Magnetic Resonance analysis 
(MAS- NMR) 
 
The 29Si MAS-NMR spectrum obtained for the porous glass ceramic and the results of 
its deconvolution before implementation are presented  by  Fig. 6 and table 1. It 
highlights the location of 2 distinct contributions at -78 ppm and -89 ppm. There are 
characteristics of the tetrahedral silicon environment Q2 and Q3 respectively. Q2 
represents  21%  whereas Q3 shows 79%. Q2 and Q3 were calculated by the integrate 
model  DM-FIT 32 software. In a previous study, the deconvolution of the 29Si MAS-
NMR spectrum of 46S6 showed the presence of Q2 (80%) and Q3 (20%) respectively at 
-78 and -87 ppm. Thus, we notice the inversion of proportions of Q2 and Q3 species. 
This is may be explained by the crystallization induced by the thermal treatment during 
the synthesis process of glass ceramic . According to the literature, Ca2+ cations are 
associated with Q2 species while Na+ cations are associated with  Q3 species. The 29Si 
MAS-NMR spectrum shows  some structural modifications due to the chemical reaction 
between glass ceramic and the in vivo biological fluid. The spectrum of control bone 
exhibits no silicon resonance. It confirms the absence of this nucleus within the bone 
matrix. After one and four months of implementation, we notice the reduction of these 
Q2 and Q3 species suggesting  the progressive degradation of the biomaterial. The 
decrease of these species is accompanied by the emergence, the development and the 
increase of new species (Q4), implying the perturbation of the vitreous matrix of 46S6-
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10Zn. The Q4 species characterize condensation of the network and the formation of a 
silicon-rich layer on the surface of the biomaterial. After 6 months, we observe the 
disappearance of these Q2, Q3 and Q4 species which explains the total degradation of the 
biomaterial (Fig. 6). The 31P MAS-NMR spectrum obtained for the glass ceramic and 
the results of its deconvolution before and after implementation are presented in Fig. 7 
and Table 3. It highlights the location of 2 distinct contributions at 3 ppm and 8 ppm.  
Based on the half height widths, which are located at the position of 1 and 15 ppm, we 
attributed the resonance of 3ppm to a crystalline phase noted Q0C and the other of 8 ppm 
to an amorphous phase named Q0a. Both populations are present respectively with 52% 
and 48%. Thus, we show an equivalent distribution of phosphorus between the 
amorphous and the crystallized phases. The 31P MAS-NMR spectrum obtained for the 
bioglass pure and the results of its deconvolution before implementation (Table 3) 
illustrates a chemical displacement which characterizes phosphorus in an 
orthophosphate environment PO43-  which corresponds to the species Q0C. The 31P 
MAS-NMR spectrum of the implanted 46S6-10Zn (Fig. 7 and Table 4) shows some 
structural modifications. These changes are due to the chemical reaction between glass 
and the in vivo biological environment. Therefore, bone illustrates the presence of 
species, with a chemical displacement of 4 ppm and with half height width of 3ppm , 
illustring thus, the presence of the carbonate hydroxyapatite (Q0HA). After one month, 
we show a sharp decrease of the Q0C, this highlights the release of phosphorus from the 
crystallized phases of the glass ceramic under the effect of the surrounding 
environment. After, four months,  this species disappeared. The Q0a species also 
decreased with the implementation time advance, but its attenuation is weaker than the 
other of Q0C. These two phases: crystallized and amorphous phases participate in the 
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formation of an apatite layer on the surface of the porous glass ceramic. But the largest 
participation is assured by crystallized phase, which accelerates the degradation of 
biomaterials. Whereas, after one month, Q0HA species, characteristic of hydroxyapatite 
phosphorus,  was formed  and was located at 4 ppm. This population increased and 
achieved  80% after six months of implementation. This data highlights the maturation 
and the mineralization of newly formed bone tissue. 
 
3.5 Histological studies 
 
All the rabbits presented satisfactory postoperative results, with no evidence of 
inflammation or infection at the surgical site. No adverse reaction was observed during 
the procedure. This explains the non toxicity of this biomaterial. Regardless of the type 
of specimen, after one month (Fig. 8), new bone was observed at the implant-bone 
interface, this explains the biocompatibilty of our composite which was accepted by the 
body and interacts with its biological system. Therefore, this tissue at the interface 
bone- bioimpalant is the results of the exchange between biological systems and 46S6-
10Zn which lead to the formation in the first time of an osteiod tissue and after one 
month this tissue is matured and transformed to a trabecular tissue leading to the 
osseointegration four months later (Fig. 9). New bone was observed growing into the 
pores and lead to the formation of calcified bone network. Indeed, this network of these 
cells is formed from mesenchymal cells, which will be transformed into fibroblasts 
contained in the collagen bundles which are deposited without apparent orientation. 
Fibroblasts metamorphosed into active osteoblasts, which are elongated along spans of 
mineralized bone tissue. The ossification is setting up step by step from the periphery to 
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the center and therefore centripetally. This result highlights the pores importance  in the 
neovascularization and the integration of newly formed bone cells in the biomaterial. 
During this staining technique, we have used a colorant which alters the biomaterial 
leading to the appearance of yellowish ranges within the bone matrix. The new growth 
bone is most abundant in the peripheral regions of the implanted zone, near to the bone 
contact zones. The initiation was done in contact with the biomaterial but never afar of 
old bone. Toward, the center of the implanted zones, the pores are denser and the 
cellularity and bone quantity is lower. The contact between the new growth bone and 
the material is intimate without fibrous interface or encapsulating. The bone "flows" are 
clearly guided by the 46S6-10Zn pores and seem building bridges from the periphery of 
bone loss (Fig. 9).  Nine months later, the rest of the 46S6-10Zn is invaded by 
connective tissue. Thereby, from the periphery to the center we see the presence of a 
fibrocartilaginous tissue, then we show the presence of trabecular bone tissue and in the 
middle we illustrate the presence  of a fibrous connective tissue which mingles with the 
rest of biomaterial (Fig. 10, 11). It represents the neosynthesis sign. This result suggests 
the degradation of biomaterial and its replacement firstly with an osteoid tissue, which 
developed and transformed in calcified tissue. 
 
4. Discussion: 
 
Owing to its bioactivity, the 46S6-10Zn induces the formation of a hydroxyapatite layer 
at its interface after its immersion in SBF solution [7]. In this study based on in vivo 
assays, the biocompatibility of this composite is confirmed by its progressive 
degradation and its replacement by a newly formed hydroxyapatite layer. XRD 
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diffractogram of 46S6-10Zn, after its implementation, shows changes with time 
progression. Therefore, after one month, we observe the presence of peaks characteric 
of  46S6-10Zn composite.  This explains the slow dissolution of the composite 46S6-
10Zn. This result is confirmed by its behavior when it was in contact with biological 
fluids. Therefore, a smaller dissolution of the ceramic glass matrix (46S6-10Zn) 
generates a smaller formation of the silica rich layer [7]. Four months later, we saw the 
disappearance of the peaks of Na4Ca4Si6O18 and Na2Ca4(PO4)2SiO4 phases and the 
appearance of two halos at  2Ɵ  values of 26° and 32°, which correspond respectively to 
(002) and (211) hydroxyapatite reflection planes. Finally, after nine months, XRD 
pattern is similar to that of the control bone and exhibits the biocompatibility and the 
chemical reactivity of our composite. FTIR analyses of the reacted material after 
implementation show some alterations of the biomaterial. This is due to several 
reactions between bone and 46S6-10Zn.  Thus, after one month, the presence of amide I 
at a wave- number of 167 cm-1 indicates the mineralization of bone tissue [18-19]. After 
four and nine months, the crystallization and the changing of 46S6-10Zn is seemed by 
the appearance of all peaks characterizing biological apatite. This data highlights the 
bioactivity of our composite.  It has been demonstrated that dissolution products from 
bioactive glasses up -regulate the expression of genes that control osteogenesis [20, 21], 
which explains the high rate of bone formation in comparison to other inorganic 
ceramics such as hydroxyapatite [22]. 
    The degradation of the composite (46S6-10Zn) with time of implantation is seemed 
by its progressive degradation in favor of the formation and crystallization of new bone. 
Moreover, the crystallization of the new formed apatite layer is poor. Therefore, we 
notice the appearance of bands characterizing a stretching vibration of C = O of the 
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amide I [18, 19], with the persistence of the maximum characterizing the porous glass 
ceramic. Four months later, it was nearly completely degraded and replaced by bone 
tissues reported by the appearance of all bands charactering bone. Therefore, the band at 
1542 cm-1 (amide II) arising from the combination of C-N stretching and N-H bending 
vibrations of the protein bone can be related to the protein matrix formation of 
implanted bone [18, 19]. The crystallization of this HA layer is more shown by the 
appearance of amide II [18, 24] and carbonate bands [18, 19]. All results highlight the 
deposition of the apatite layer upon to the silicon layer when brought in contact with 
body fluids [25, 27]. Nine months later, all these bands increase in intensity and take the 
same form of biological apatite of bone. The contact between the biomaterial surface 
and the SBF solution leads to the formation of a hydrated silica layer on this surface and 
induces the deposition of HA. Silanol groups could be specific sites of apatite 
nucleation [7]. 
   The bioactivity of 46S6-10Zn after its implementation depends on its chemical 
composition [27]. The amounting of Ca/P ratio over time is an indication of progressive 
mineralization with time progressing. This finding highlights the good role of Zn in the 
mineralization of the interface:  bone- 46S6-10Zn. The incorporation of mineral ions 
such as zinc or silicate in calcium phosphate ceramics showed an increase of osteoblasts 
attachment and proliferation [28]. After one month of implementation, the slowly 
decreasing of Si in the interface of 46S6-10Zn is explained by the slowly dissolution of 
biomaterial which leads to its release. The increasing of Si  may be due to the breaking 
of the Si-O-Si bond and favorites the formation of Si-OH and Si(OH)4 groups at the 
glass/bone interface and which induces heterogeneous nucleation of the apatite with the 
progression time. Orthosilicate acid, Si(OH)4, has been shown to stimulate osteoblastic 
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differentiation and the formation of type I collagen in human osteoblasts [29]. Whereas, 
after four and nine months, the silicon value decreased and tended to 0 after nine 
months, this highlights the degradation of the porous glass ceramic and its replacement 
by bone cells. Data reported by the MAS-NMR confirm the previous findings reported 
by the other analyses.  
Therefore, 29Si MAS-NMR spectra of the implanted 46S6-10Zn illustrate the decreasing 
of  Q2 and Q3 species, with time progression, in favor of the increasing  of Q4. This 
result demonstrates the degradation of the biomaterial and the formation of a silicon-
rich layer on the surface of the biomaterial . Surface hydroxyl groups play an important 
role in bioactivity [3]. Silica gel in the bioactive glass surface provides a large number 
of silanol (Si-OH) terminations, which flex to match the crystals of hydroxyapatite and 
act as nucleation sites [30]. After six months, these species are disappearing. This 
exhibits the degradation of our composite and its replacement by bone. Glass bioactivity 
leads to both osteoconduction and osteoproduction [31] as a consequence of rapid 
reactions on the bioactive glass surface. 
  The 31P MAS-NMR spectrum obtained for the glass ceramic and the results of its 
deconvolution before implementation, demonstrate the location of 2 distinct 
contributions at 3 ppm and 8 ppm. There are  characteristics of phosphorus species of an 
orthophosphates environment Q0 [32]. The attenuation of species Qa0 and Qc0 with time 
progression and the increasing of QHA0 highlight the degradation of bioimplant and its 
replacement by the bone. These findings exhibit also the bioactivity of our composite in 
the first time and in the second time the good effect of Zn incorporation in the vitreous 
matrix which stimulates osteobalst formation and inhibits osteoclast differentiation. To 
better understand the evolutionary phenomena of the degradation of the hybrid (46S6-
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10Zn) and its replacement by a new calcified bone, we have deepened our 
physicochemical study by histological exploration. Therefore, the degradation of this 
composite increased with time progression in favor of bone mineralization. These 
findings are correlated to the bioacompatibility, the degradability and the presence of 
pores which ensure the integration of bone cells in biomaterial. This osseointegration 
phenomena  increase with time progression and lead to almost total degradation of 
46S6-10Zn. The increasing microporosity may provide an increased surface area for the 
action of angiogenic and other proteins leading to the formation of blood vessels and 
promoting bone induction by osteoblasts at early time points [33, 34]. In the other hand, 
it is may be due to the presence of Zn in the vitreous matrix of 46S6-10Zn and which 
encouraged the differentiation and the development of mineralized bone tissue. Zinc is 
an essential trace metal known to have stimulatory effects on bone formation in vitro 
and in vivo studies [35]. 
 
5. Conclusion 
 
This study aimed to evaluate the behavior of our porous glass ceramic doped with Zn 
and Ti (46S6-10Zn) before and after its implementation in bone defect. This evaluation 
realized by several physico-chemical explorations through XRD, FTIR, EDS and 29Si, 
31P MASS-NMR. Therefore, XDR and FTIR illustrate the degradation and the 
neoformation of bone by the disappearance of peaks characterizing amorphous and 
crystalline phases of 46S6-10Zn, and their replacement by peaks similar to those of 
biological apatite. Moreover, EDS shows the mineralization of bone tissue by the 
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increasing of Ca/P ratio with time progression from 1.33 after one month to 1.88 nine 
months later. Also, it highlights progressive degradation of 46S6-10Zn, as indicated 
by the reduction of Zn and Si concentrations with time progression. MAS-NMR 
illustrates the degradation of biomaterial, then 29Si MAS-NMR indicates the 
disappearance of Q2, Q3 and Q4 species after six months of implementation. Whereas 
31P MAS-NMR shows the disappearances of Q0C and Q0a species in favor of the 
development of Q0HA. Finally, histological exploration illustrates the osseointegration 
and the biodegradation of the composite by the progression of the osteoblasts’ 
deposition in the pores of biomaterial leading after nine months to it’s totally 
degradation and its replacement by mineralized and osteoid bone. All these data 
highlight the good effect of incorporation of Zn and Ti in the matrix of bioglass.  
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Figures captions: 
 
Figure 1: Steps of surgical operation 
Figure 2: XRD pattern of porous glass ceramic doped with Zinc (46S6-10Zn) before 
and after one, four and nine months of implementation in critical diaphyseal bone defect 
in rabbit. 
Figure 3: FTIR spectra of porous glass ceramic doped with zinc (46S6-10Zn) before and 
after one, four and nine months of implementation in critical diaphyseal bone defect in 
rabbit. 
Figure 4: Ca/P ratio (EDS) obtained from the chemical analysis of the porous glass 
ceramic doped with Zinc (46S6-10Zn) before and after one, four and nine months of 
implementation in critical diaphyseal bone defect in rabbit. 
Figure 5: Si and Zn value (EDS) obtained from the chemical analysis of the porous 
glass ceramic doped with Zinc (46S6-10Zn) before and after one, four and nine months 
of implementation in critical diaphyseal bone defect in rabbit. 
Figure 6: 29Si MAS-NMR spectra of porous glass ceramic doped with zinc (46S6-10Zn) 
before and after one, four and six months of implementation in critical diaphyseal bone 
defect in rabbit.  
Figure 7: 31P MAS-NMR spectra of porous glass ceramic doped with zinc (46S6-10Zn) 
before and one, four and six months after implementation in critical diaphyseal bone 
defect in rabbit.  
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Figure 8:  Goldner’s trichrome staining (10 × objective). Histological sections of the 
interface between porous glass ceramic (46S6-10Zn) and bone after one month after 
implementation in critical diaphyseal bone defect in rabbit:  
* indicates porous glass ceramic doped with zinc (46S6-10Zn) 
# indicates mineralized bone 
Figure 9:  Goldner’s trichrome staining (10 × objective). Histological sections of the 
interface between porous glass ceramic (46S6-10Zn) and bone four months after 
implementation in critical diaphyseal bone defect in rabbit:  
* indicates porous glass ceramic doped with zinc (46S6-10Zn) 
 #indicate mineralized bone and 
 @ indicate the osteoid bone. 
Arrows: indicates the osseointegration process 
Figure 10:  Goldner’s trichrome staining (10 × objective). Histological sections of the 
interface between porous glass ceramic (46S6-10Zn) and bone after nine months of 
implementation in critical diaphyseal bone defect in rabbit:  
#indicate mineralized bone and  
Arrows indicate the osteointegration process. 
Figure 11:  Goldner’s trichrome staining (10 ×objective). Histological sections of the 
interface between porous glass ceramic (46S6-10Zn) and bone after nine months of 
implementation in critical diaphyseal bone defect in rabbit:  
# indicates mineralized bone and  
@ indicate the osteoid bone. 
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Tables captions : 
 
Table 1: Contribution and chemical shifts of different species in 29Si spectra of bioactive 
pure glass (46S6) and porous glass ceramic doped with zinc (46S6-10Zn) before 
implementation.  
Table 2: Contribution and chemical shifts of different species in 29Si spectra of porous 
glass ceramic doped with zinc (46S6-10Zn) after one, four and six months after 
implementation. 
33 
 
Table 3: Contribution and chemical shifts of different species in 31P spectra of bioglass 
pure (46S6) and porous glass ceramic doped with zinc (46S6-10Zn) before 
implantation. 
Table 4: Contribution and chemical shifts of different species in 31P spectra of porous 
glass ceramic doped with zinc (46S6-10Zn) after one, four and six months of 
implementation 
 
 Q2 Q3 
δ (ppm) % δ (ppm) % 
Pure bioactive glass (46S6) -79 80 -87 20 
Porous glass ceramic doped 
with zinc (46S6-10Zn) 
-79 21 -89 79 
 
 
 Q2 Q3 Q4 
δ (ppm) % δ (ppm) % δ (ppm) % 
1 Month -79 25 -89 73 -108 4 
4 Months -79 19 -89 58 -108 23 
6Months 0 0 0 0 0 0 
Control bone 0 0 0 0 0 0 
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 Q0c Q0a 
δ (ppm) % δ (ppm) % 
Pure bioactive glass 
 (46S6) 
7.5 100 0 O 
Porous glass ceramic 
doped with Zinc (46S6-
10Zn) 
3 52 8 48 
 
 
              Q0c              Q0HA                   Q0a 
δ (ppm) % δ (ppm) % δ (ppm) % 
1 Month 3 4 4 55 8 41 
4 Months 3         0 4 71 8 29 
6 Months 3 0 4 80 8 20 
Control bone 0 0 4 100 0 0 
 
 
